2 While the pandemic has created opportunities for the biopharma industry to demonstrate the industrys value, it also has led to potential short- If this is the case, the company has more than enough cash to meet its liabilities while using its capital effectively. Within Healthcare sector 5 other industries have achieved higher asset turnover ratio. Successfully managing debt obligations is a major factor in the long-term viability and profitability of any pharmaceutical company. calibrated vs uncalibrated radiocarbon dates Menu Accounts payable turnover ratio is used to measure a companys capacity of short-term liquidity. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc. Dollars, and therefore it is the second-largest region in the pharmaceuticals market. On the trailing twelve months basis Despite sequential decrease in Current Liabilities, Quick Ratio detoriated to 0.77 in the 4 Q 2022 below Major Pharmaceutical Preparations Industry average. Roche was established in 1896. We are happy to help you with everything and also offer free training. Calculation: Current Assets / Current Liabilities. According to Statista, the entire global pharmaceutical market was estimated to be worth around 1.27 trillion U.S. dollars as of the end of -2020. The debt ratio measures the amount of leverage that a company has and indicates the proportional amount of a companys assets that are financed through debt. Return On Tangible Equity. Compare PFE With Other Stocks. The quick ratio is a financial metric used to measure short-term liquidity. Teva has strengthened its position in Europe through its acquisition of Germany's second largest generics producer, ratiopharm. However, this ratio has to be analyzed over a period of time to understand trends and in comparison with industry benchmarks. What Are the Average Research and Development Costs for Pharmaceutical Companies? To make informed choices, investors need to consider the key financial ratios that are most helpful in the analysis and equity evaluation of pharma firms. The cookie is used to store the user consent for the cookies in the category "Performance". Quick Ratio total ranking fell in contrast to the previous quarter from to 12. Dollars in revenue, was the top-performing pharmaceutical product in 2021. They were the first to approve the use of a vaccine in the United States and were included in the TIME100Most Influential Company List for 2021. The worlds regions with the highest compound annual growth rates are Latin America and India Subcontinent, which will be the case until 2025. Note, Numbers include only companies who have reported earnings results. It controls many of the worlds largest pharmaceutical companies, including Genentech (USA), Chugai Pharmaceuticals (Japan), and Ventana (USA). A competent financial analyst will refer to a good mix of ratios before arriving at any conclusion. ideal current ratio for pharmaceutical industryshort farewell speech by students leaving college ideal current ratio for pharmaceutical industry. It is used to measure a companys operating performance and when annually calculated, reveals the managements ability to use significant assets of the company to generate revenue. In simple terms, financial ratios are the relationship established between various statistical data provided in the companys financial documents such as the balance sheet, income statement, cash flow statements, etc. Built using WordPress and the Highlight Theme. China is the biggest market in this region. 15.11.2017. Eli Lilly and Company is well known for its clinical depression drugs Prozac (1986), and Cymbalta (2004) as well as antipsychotic medication Zyprexa (1996). Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features. Share Price 958.9: Mar 01,2023 . Pharmaceutical Preparations: average industry financial ratios for U.S. listed companies Industry: 2834 - Pharmaceutical Preparations Measure of center: median (recommended) average Financial ratio Top 10 Pharma Trends in 2022 1. Discover the right bonds meeting your investment amount & investment horizon, Fundamental, Stock Ideas, Multibaggers & Insights, Stock & Index F&O Trading Calls & Market Analysis, Commodity Trading Calls & Market Analysis, Currency Derivatives Trading Calls & Insights, Options Trading Advice and Market Analysis, Model portfolios, Investment Ideas, Guru Screens and Much More, Proprietary system driven Rule Based Trading calls, Curated markets data, exclusive trading recommendations, Independent equity analysis & actionable investment ideas, Details stock report and investment recommendation, 15-20 High Growth Stocks primed for price jumps, +272.45 (+1.57%) The expected growth of the global pharmaceuticals market in 2020 is $1228.45 billion, with 2021 reaching $1250.24 billion. This article was updated on November 2, 2021. Brazil was the South American country with the largest pharmaceutical market value at nearly 21 Billion U.S. dollars in 2020. The current ratio is an essential financial matric that helps to understand the liquidity structure of the business. Investors seeking to invest in the best pharmaceutical companies are faced with a wide array of publicly traded companies from which to choose. Around 15% of the total market supply of pharmaceuticals is produced in domestic markets. Scores higher than 1 indicates good health of the companys debt scenario. Its especially helpful for the businesses lenders that assessability of the business to repay their dues. You can calculate it using the turnover ratio formula: This ratio will vary with industry based on the measure of their fixed assets. Miscellaneous Fabricated Products Industry, Industrial Machinery and Components Industry, Renewable Energy Services & Equipment Industry, Miscellaneous Financial Services Industry, Major Pharmaceutical Preparations Industry, Laboratory Analytical Instruments Industry, In Vitro & In Vivo Diagnostic Substances Industry, Print Media & Newspaper Publishing Industry, Computer Peripherals & Office Equipment Industry, Internet Services & Social Media Industry, Electronic Instruments & Controls Industry, Computer processing and cloud services Industry, Scientific & Technical Instruments Industry, Internet, Mail Order & Online Shops Industry, Pharmacy Services & Retail Drugstore Industry, More Major Pharmaceutical Preparations Industry historic financial strength information >>, Compare Industry's quick ratio to Wkhs's or S&P, Constituent list of Major Pharmaceutical Preparations Industry. Get Standard Medical Pharmaceuticals latest Key Financial Ratios, Financial Statements and Standard Medical Pharmaceuticals detailed profit and loss accounts. It is at the forefront of immunology, oncology, ophthalmology infectious diseases, and neuroscience. Despite the exponential growth curve, our AUM to GDP ratio is significantly low at 16% as compared to a global average of 74%. Lincoln Pharmaceuticals 5. We have also compiled a comprehensive database of the IRS financial ratios by industry which will act as quick reference for your respective businesses. . Anuh Pharma 3. In the kingdom, there are about 15-20 pharmaceutical manufacturers, which include local companies and subsidiaries of multinational pharmaceutical companies. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. ROI. The Current P/S Ratio of SUN PHARMACEUTICAL INDUSTRIES is 5.47. Despite being the leading COVID-19 vaccine manufacturer in North America, Pfizer slid in the rankings to third place. ). The best of the best: the portal for top lists & rankings: Strategy and business building for the data-driven economy: Pharmaceutical market: worldwide revenue 2001-2022, Global pharmaceutical market - revenue distribution 2010-2021, by region, Top therapeutic classes by global pharmaceutical sales 2018 estimates, Total global pharmaceutical R&D spending 2014-2028, Number of novel drugs approved annually by CDER 2008-2022, Revenue of the worldwide pharmaceutical market from 2001 to 2022 (in billion U.S. dollars), World pharmaceutical sales 2017-2021 by region, Global pharmaceutical sales from 2017 to 2021, by region* (in billion U.S. dollars), World pharmaceutical market distribution by submarket 2014-2021, Distribution of the total global pharmaceutical market sales from 2014 to 2021, by submarket*, Revenues of top 10 global pharmaceutical markets 2021, Revenues of top 10 national pharmaceutical markets worldwide in 2021 (in billion U.S. dollars), Top pharmaceutical products by sales worldwide 2021, Leading pharmaceutical products by sales worldwide in 2021 (in billion U.S. dollars), Share of pharmaceutical value worldwide 2021, by country, Value share of the pharmaceutical market worldwide as of November 2021, by country*, Value share of pharmaceutical subsectors worldwide 2003 vs. 2021, Value share of the pharmaceutical market worldwide in 2003 and 2021, by subsector*, Top therapy classes by spending global market 2026 forecast, Projected top therapy areas worldwide in 2026, by spending (in billion U.S. dollars), Global pharmaceutical revenue by technology 2012-2026, Global pharmaceutical revenue distributed by technology from 2012 to 2026 (in billion U.S. dollars), Worldwide Rx drug sales excluding generics and orphan drugs 2012-2026, Prescription drugs sales worldwide excluding generics and orphan drugs from 2012 to 2026 (in billion U.S. dollars), Projection of global revenue for orphan prescription drugs 2012-2026, Global prescription orphan drug sales from 2012 to 2026 (in billion U.S. dollars), Worldwide generic prescription drug sales 2012-2026, Worldwide generic prescription drug sales from 2012 to 2026 (in billion U.S. dollars), Revenue of the global OTC pharmaceutical market 2016-2027, Revenue of the global OTC pharmaceutical market from 2016 to 2027 (in billion U.S. dollars), Global oncology spending from 2011 to 2023 (in billion U.S. dollars), Tota pharmaceutical value worldwide 2021, by subsector, Total pharmaceutical value worldwide as of November 2021, by subsector* (in million U.S. dollars), Top 50 pharmaceutical companies - Rx sales and R&D spending 2021, Leading 50 global pharmaceutical companies by prescription sales and R&D spending in 2021 (in billion U.S. dollars), Global Rx drug market share by top companies 2019 and 2026, Top 20 pharmaceutical companies worldwide based on prescription drug market share in 2019 and 2026*, Top 10 biotech and pharmaceutical companies based on market cap 2022, Leading 10 biotech and pharmaceutical companies worldwide based on market capitalization as of 2022 (in billion U.S. dollars), Pfizer's total revenue from 2006 to 2021 (in million U.S. dollars), Novartis AG's total revenue from 2007 to 2022 (in billion U.S. dollars), Total sales of the Roche Group from 2006 to 2022 (in million Swiss francs), Johnson & Johnson's total sales 2005-2022, Johnson & Johnson's total sales from 2005 to 2022 (in million U.S. dollars), Projected top pharmaceutical companies based on new sales 2023, Leading pharmaceutical companies worldwide based on projected sales increase during 2023 (in billion U.S. dollars), Total global spending on pharmaceutical research and development from 2014 to 2028 (in billion U.S. dollars), Global top pharmaceutical companies based on R&D spending 2026, Global top 10 pharmaceutical companies based on projected R&D spending in 2026 (in billion U.S. dollars), Patent expiration risks for total worldwide prescription drug revenue 2020-2028, Worldwide total prescription drug revenue at risk from patent expiration from 2020 to 2028 (in billion U.S. dollars), Worldwide prescription drug revenue - market risk from patent expiration 2020-2028, Share of global prescription drug revenue at risk from patent expiration from 2020 to 2028, Pharmaceutical industry - number of new substances 1998-2021, Number of new chemical or biological entities developed between 1998 and 2021, by region of origin, Pharma companies worldwide with active R&D pipelines 2001-2022, Total number of pharmaceutical companies with active R&D pipelines worldwide from 2001 to 2022, Total number of novel drugs approved by CDER from 2008 to 2022, Projected most valuable R&D projects based on net present value 2022, Selected top pharmaceutical R&D projects based on net present value (NPV) as of December 2022 (in billion U.S. dollars), World pharmaceutical sales by region forecast 2025, Projected global pharmaceutical sales for 2025, by region* (in billion U.S. dollars), Global spending on medicines in 2010, 2021, and a forecast for 2026 (in billion U.S. dollars), CAGR by product type in pharmaceutical markets forecast 2022-2026, Projected pharmaceutical spending CAGR worldwide between 2022 and 2026, by market and product type, Country comparison in spending on medicine 2026, Projected spending on medicine of selected countries worldwide in 2026 (in billion U.S. dollars), Leading global pharmaceutical products by projected sales 2026, Projected top 10 global pharmaceutical products by sales in 2026 (in million U.S. dollars), Top global biopharma drugs by lifetime sales up to 2026, Projected top 10 pharmaceutical products worldwide based on lifetime sales as of 2026 (in billion U.S. dollars), COVID-19 vaccine dose numbers by top manufacturer 2021, Drug manufacturers with the highest number of ordered COVID-19 vaccine doses as of March 2021* (in million doses), Top companies by COVID-19 treatment vaccines in development June 2022, Leading companies by number of COVID-19 drugs and vaccines in development as of June 3, 2022, Number of COVID-19 drugs in development worldwide by phase June 2022, Number of coronavirus (COVID-19) drugs and vaccines in development worldwide as of June 3, 2022, by phase, BARDA funding for the development of COVID-19 vaccines in the U.S. 2021, BARDA funding for the development of COVID-19 vaccines in the United States as of March 2021* (in million U.S. dollars), Forecasted sales of select COVID-19 vaccines worldwide 2021-2022, Forecasted sales of select COVID-19 vaccines worldwide in 2021 and 2022 (in billion U.S. dollars), Gilead Science's remdesivir manufacturing projections 2020, Cumulative amount of remdesivir treatment courses projected to be manufactured by Gilead Sciences during 2020 (in 1,000s), Global mRNA vaccines and therapeutics market for COVID-19 Q4 2020 vs. 2025, Global mRNA vaccines and therapeutics market for COVID-19 in Q4 2020 and a forecast for Q4 2025 (in million U.S. dollars).